Corcept Therapeutics
CORT
#2956
Rank
A$6.62 B
Marketcap
$63.37
Share price
3.25%
Change (1 day)
26.96%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of June 2024 : A$0.70 B

According to Corcept Therapeutics 's latest financial reports the company has A$0.70 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.54 B-14.8%
2022-12-31A$0.63 B106.34%
2021-12-31A$0.30 B-46.25%
2020-12-31A$0.57 B45.68%
2019-12-31A$0.39 B33.8%
2018-12-31A$0.29 B158.1%
2017-12-31A$0.11 B58.99%
2016-12-31A$71.49 M28.8%
2015-12-31A$55.51 M87.73%
2014-12-31A$29.57 M-51.94%
2013-12-31A$61.52 M-31.43%
2012-12-31A$89.72 M132.13%
2011-12-31A$38.65 M59.23%
2010-12-31A$24.27 M-9.03%
2009-12-31A$26.68 M0.66%
2008-12-31A$26.5 M33.39%
2007-12-31A$19.87 M65.68%
2006-12-31A$11.99 M-69.82%
2005-12-31A$39.74 M-17.77%
2004-12-31A$48.33 M210.3%
2003-12-31A$15.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$38.20 B 5,284.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.97 B 1,306.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.65 B 1,682.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$5.04 B 610.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.65 B 1,400.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.02 B 2,299.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.28 B-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.37 B-47.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.83 B 158.76%๐Ÿ‡บ๐Ÿ‡ธ USA